News items Two science talents to foreign top institutes with Rubicon
21 June 2021

Radboud university medical center researchers Guido van Mierlo and Michelle Brouwer receive a Rubicon grant from Dutch scientific organization NWO. This grant is intended for young scientists with a doctoral degree to conduct research at foreign research institutes. The Rubicon program is intended to give young, promising scientists the opportunity to gain international research experience.

Unexpected player in brain development – Michelle Brouwer

Michelle Brouwer will work in Belgium at Vlaams Instituut voor Biotechnologie for two years. Her research is about our immune system, that possesses an arsenal of deadly proteins to attack pathogens. Surprisingly, one of these proteins appears important for normal brain development. She will therefore investigate how this protein exactly functions in the brain.

Translating the communication between DNA – Guido van Mierlo

Guido van Mierlo will work in Switzerland for 24 months at École polytechnique fédérale de Lausanne (EPFL). His research is about our DNA, that contains the information essential for our life. The researcher will develop novel tools to investigate how (disturbed) collaboration between pieces of DNA contributes to the onset of disease, or rather protection against this.

About Rubicon

Experience abroad is an important step in the career of many scientists. The Rubicon grant allows young researchers to conduct their research at top institutions such as Stanford and Harvard. The majority of researchers go abroad for 24 months. A total of 26 Rubicon researchers go abroad for 24 months, with the other 19 laureates going away for between 12 and 18 months.

With a Rubicon funding, scientists can spend up to 24 months doing research at a foreign research institution. The amount of funding depends on the chosen destination and the length of stay. Each year NWO can fund around 60 young researchers within Rubicon (for a total amount of seven million euros, divided over three rounds). The awards from this post concern two merged 2020 funding rounds.

More information

Pauline Dekhuijzen

wetenschaps- en persvoorlichter

neem contact op

Related news items

Rubicon grants awarded to three RIMLS researchers

19 April 2022

Three researchers have received Rubicon funding from NWO/ZonMw. This will enable Elke Muntjewerff, Laura de Vries and Laurens van de Wiel to do research at a foreign research institute for the next two years.

read more

Neolithic made us taller and more intelligent, but more prone to heart disease How modern European populations have evolved over the past 50,000 years

6 April 2022

After the Neolithic, European populations showed an increase in height and intelligence, reduced skin pigmentation and increased risk of cardiovascular disease due to genetic changes that lowered concentrations of 'good' HDL cholesterol.

read more

Immunogenetic studies in diverse populations are essential Clear immunological differences between populations in Europe and Africa

15 February 2022

Genetic factors that partly determine host defenses sometimes differ significantly between people and populations. This is shown in a publication in the American Journal of Human Genetics by researchers from the Netherlands, Tanzania and India.

read more

NIH grant for follow-up research on tuberculous meningitis

10 February 2022

Met subsidie van het Amerikaanse NIH gaat With a grant from the U.S. NIH, Reinout van Crevel will continue to unravel the disease process of tuberculous meningitis.

read more

What does the shingles vaccine teach us about other vaccines? Investigating the role of trained immunity

27 January 2022

The vaccine for shingles, a condition that causes itching, pain, and blisters, is 90% effective, even in elderly. This is remarkable, since most vaccines offer less protection in elderly. Radboudumc is investigating why this vaccine works so well and how it might help us to develop better vaccines.

read more